Protein (1)
Launched (1)
Hendra virus (1)
His Tag (1)
Unconjugated (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
FUN-H52H4 | Hendra virus | HEK293 | Hendra virus Pre-Fusion glycoprotein (A263T), His Tag | ![]() |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Nangibotide | LR-12 | Phase 2 Clinical | Inotrem | Shock, Septic; Coronavirus Disease 2019 (COVID-19) | Details |
| CEL383 | CEL-383 | Phase 1 Clinical | Celsius Therapeutics Inc | Inflammatory Bowel Diseases | Details |
| ABBV-8736 | ABBV-8736 | Phase 1 Clinical | Abbvie Inc | Inflammatory Bowel Diseases | Details |
| TREM 1 antibody(Boehringer Ingelheim International Gmbh) | TREM 1 antibody(Boehringer Ingelheim International Gmbh) | Phase 1 Clinical | Boehringer Ingelheim International Gmbh | Immune System Diseases | Details |
| PY-159 | PY-159 | Phase 1 Clinical | Centre for the Commercialization of Antibodies and Biologics | Solid tumours; Neoplasms | Details |

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland




